Clinical Trial Update: Comparison of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compared Hylastan to methylprednisolone acetate for symptomatic knee osteoarthritis and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Hylastan
• Methylprednisolone acetate (Methylprednisolone acetate)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Osteoarthritis, Knee | Phase 3 | Status: COMPLETED